Tellgen Corporation
300642
Rank in Stocks
#13864
Tellgen Corporation is dedicated to the creation, manufacturing, and supply of... Tellgen Corporation is dedicated to the creation, manufacturing, and supply of in-vitro diagnostic (IVD) solutions, serving both the Chinese domestic market and a global clientele. Their extensive product catalog includes cancer detection markers, test kits for human papilloma virus (HPV), ToRCH diagnostic assays, Y-chromosome microdeletion screening kits, and sophisticated multiplex immunoassay systems. The company, founded in 2003, operates from its headquarters in Shanghai, China.
Share Price
$2.79
Market Cap
$453.38M
Change (1 day)
4.39%
Change (1 year)
-25.61%
Country
CN
Trade Tellgen Corporation (300642)
Category
Healthcare
P/B ratio for Tellgen Corporation (300642)
P/B ratio as of 2026 TTM: 0
According to Tellgen Corporation latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Tellgen Corporation from 2026 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| 3.5116 | - |
US
|
|
| 2.0146 | - |
IE
|
|
| 4.5025 | - |
US
|
|
| 2.5486 | - |
US
|
|
| - | - |
DE
|
